Tuberculose ultrarésistante aux médicaments : Questions médicales fréquentes
Nom anglais: Extensively Drug-Resistant Tuberculosis
Descriptor UI:D054908
Tree Number:C01.150.252.410.040.552.846.775.500
Termes MeSH sélectionnés :
Linear Models
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tuberculose ultrarésistante aux médicaments : Questions médicales les plus fréquentes",
"headline": "Tuberculose ultrarésistante aux médicaments : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tuberculose ultrarésistante aux médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tuberculose ultrarésistante aux médicaments"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tuberculose multirésistante",
"url": "https://questionsmedicales.fr/mesh/D018088",
"about": {
"@type": "MedicalCondition",
"name": "Tuberculose multirésistante",
"code": {
"@type": "MedicalCode",
"code": "D018088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.846.775"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tuberculose ultrarésistante aux médicaments",
"alternateName": "Extensively Drug-Resistant Tuberculosis",
"code": {
"@type": "MedicalCode",
"code": "D054908",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peize Zhang",
"url": "https://questionsmedicales.fr/author/Peize%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Guofang Deng",
"url": "https://questionsmedicales.fr/author/Guofang%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Nam Xuan Vo",
"url": "https://questionsmedicales.fr/author/Nam%20Xuan%20Vo",
"affiliation": {
"@type": "Organization",
"name": "Graduate Program in Social, Economic and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand."
}
},
{
"@type": "Person",
"name": "Trung Quang Vo",
"url": "https://questionsmedicales.fr/author/Trung%20Quang%20Vo",
"affiliation": {
"@type": "Organization",
"name": "Department of Economic and Administrative Pharmacy (EAP), Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam."
}
},
{
"@type": "Person",
"name": "Getu Diriba",
"url": "https://questionsmedicales.fr/author/Getu%20Diriba",
"affiliation": {
"@type": "Organization",
"name": "Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Electronic address: getud2020@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "\"Next top\" mouse models advancing CTCL research.",
"datePublished": "2024-04-10",
"url": "https://questionsmedicales.fr/article/38665428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcell.2024.1372881"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigation of Zinc on hemorheological parameters in a rat model of diabetes.",
"datePublished": "2024-04-10",
"url": "https://questionsmedicales.fr/article/38643593",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtemb.2024.127450"
}
},
{
"@type": "ScholarlyArticle",
"name": "An optimal investment consumption model for retirees with no health insurance.",
"datePublished": "2024-04-09",
"url": "https://questionsmedicales.fr/article/38638984",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2024.e29034"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incorporating photosynthetic acclimation improves stomatal optimisation models.",
"datePublished": "2024-04-08",
"url": "https://questionsmedicales.fr/article/38589983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/pce.14891"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modelling of Musical Perception using Spectral Knowledge Representation.",
"datePublished": "2024-04-08",
"url": "https://questionsmedicales.fr/article/38617750",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5334/joc.356"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram positif",
"item": "https://questionsmedicales.fr/mesh/D016908"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Actinomycetales",
"item": "https://questionsmedicales.fr/mesh/D000193"
},
{
"@type": "ListItem",
"position": 7,
"name": "Infections à Mycobacterium",
"item": "https://questionsmedicales.fr/mesh/D009164"
},
{
"@type": "ListItem",
"position": 8,
"name": "Tuberculose",
"item": "https://questionsmedicales.fr/mesh/D014376"
},
{
"@type": "ListItem",
"position": 9,
"name": "Tuberculose multirésistante",
"item": "https://questionsmedicales.fr/mesh/D018088"
},
{
"@type": "ListItem",
"position": 10,
"name": "Tuberculose ultrarésistante aux médicaments",
"item": "https://questionsmedicales.fr/mesh/D054908"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tuberculose ultrarésistante aux médicaments - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tuberculose ultrarésistante aux médicaments",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tuberculose ultrarésistante aux médicaments",
"description": "Comment diagnostiquer la XDR-TB ?\nQuels tests sont utilisés pour la XDR-TB ?\nQuels symptômes indiquent une XDR-TB ?\nLa radiographie est-elle utile pour la XDR-TB ?\nPeut-on détecter la XDR-TB par un test rapide ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tuberculose ultrarésistante aux médicaments",
"description": "Quels sont les symptômes principaux de la XDR-TB ?\nLa douleur thoracique est-elle un symptôme ?\nLes sueurs nocturnes sont-elles fréquentes ?\nLa fatigue est-elle un symptôme de la XDR-TB ?\nPeut-on avoir des symptômes gastro-intestinaux ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tuberculose ultrarésistante aux médicaments",
"description": "Comment prévenir la XDR-TB ?\nLe port de masques est-il recommandé ?\nLa vaccination BCG est-elle efficace contre la XDR-TB ?\nLes contacts doivent-ils être testés ?\nLes soins de santé doivent-ils être formés ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tuberculose ultrarésistante aux médicaments",
"description": "Quel est le traitement standard pour la XDR-TB ?\nLes médicaments de première ligne sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements sont-ils coûteux ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tuberculose ultrarésistante aux médicaments",
"description": "Quelles sont les complications de la XDR-TB ?\nLa XDR-TB peut-elle causer des infections secondaires ?\nY a-t-il un risque de transmission accrue ?\nLes complications affectent-elles la qualité de vie ?\nLa résistance aux médicaments complique-t-elle le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tuberculose ultrarésistante aux médicaments",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes conditions de vie affectent-elles le risque ?\nLes travailleurs de la santé sont-ils à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la XDR-TB ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la XDR-TB ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la culture, le test de sensibilité et la PCR pour Mycobacterium tuberculosis."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une XDR-TB ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, fièvre, sueurs nocturnes et perte de poids."
}
},
{
"@type": "Question",
"name": "La radiographie est-elle utile pour la XDR-TB ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiographie thoracique peut montrer des lésions pulmonaires caractéristiques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la XDR-TB par un test rapide ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests rapides comme GeneXpert peuvent détecter la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la XDR-TB ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes principaux sont toux, fièvre, fatigue, et perte d'appétit."
}
},
{
"@type": "Question",
"name": "La douleur thoracique est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur thoracique peut survenir en raison de l'infection pulmonaire."
}
},
{
"@type": "Question",
"name": "Les sueurs nocturnes sont-elles fréquentes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sueurs nocturnes sont un symptôme courant de la tuberculose avancée."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme de la XDR-TB ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue persistante est souvent rapportée par les patients atteints de XDR-TB."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes gastro-intestinaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la diarrhée peuvent survenir, surtout avec des traitements prolongés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la XDR-TB ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le dépistage précoce, l'isolement des cas et la vaccination BCG."
}
},
{
"@type": "Question",
"name": "Le port de masques est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masques peut réduire le risque de transmission dans les zones à risque."
}
},
{
"@type": "Question",
"name": "La vaccination BCG est-elle efficace contre la XDR-TB ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG offre une protection limitée contre la XDR-TB, mais reste recommandée."
}
},
{
"@type": "Question",
"name": "Les contacts doivent-ils être testés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les contacts des patients doivent être testés régulièrement pour détecter la tuberculose."
}
},
{
"@type": "Question",
"name": "Les soins de santé doivent-ils être formés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la formation des professionnels de santé est cruciale pour gérer la XDR-TB efficacement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour la XDR-TB ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques spécifiques pendant au moins 18 mois."
}
},
{
"@type": "Question",
"name": "Les médicaments de première ligne sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les médicaments de première ligne ne sont généralement pas efficaces contre la XDR-TB."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent causer des effets secondaires comme nausées et hépatotoxicité."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée pour retirer des lésions pulmonaires dans certains cas."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils coûteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements de la XDR-TB peuvent être très coûteux et nécessitent un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la XDR-TB ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, la septicémie et la mort."
}
},
{
"@type": "Question",
"name": "La XDR-TB peut-elle causer des infections secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer des infections secondaires en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de transmission accrue ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la XDR-TB augmente le risque de transmission dans les communautés vulnérables."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "La résistance aux médicaments complique-t-elle le traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la résistance aux médicaments rend le traitement plus long et plus complexe."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le VIH, la malnutrition, et l'exposition à des cas de tuberculose."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour la tuberculose et ses formes résistantes."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions de vie surpeuplées et insalubres augmentent le risque de XDR-TB."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé sont exposés à un risque accru de contracter la XDR-TB."
}
}
]
}
]
}
Diabetes mellitus (DM) is a complex, chronic metabolic disorder characterized by impaired regulation of blood glucose levels. Zinc (Zn) is an essential trace elements that plays a role in various phys...
Retirees meet a number of problems as they are growing older which needs persistent attention. Hence, without a doubt, the outcomes of the financial markets influence the choices that people make when...
Stomatal opening in plant leaves is regulated through a balance of carbon and water exchange under different environmental conditions. Accurate estimation of stomatal regulation is crucial for underst...
This paper presents Maud, a command-line application that implements Bayesian statistical inference for kinetic models of biochemical metabolic reaction networks. Maud takes into account quantitative ...
Gaussian Graphical Models (GGM) have been widely used in biomedical research to explore complex relationships between many variables. There are well established procedures to build GGMs from a sample ...
Indigenous peoples around the world are revitalising their ancestral beliefs, practices, and languages, including traditional understandings of health and wellbeing. In the Aotearoa (New Zealand) cont...
Deep dermal wounds in extensive burns and chronic wound-healing disorders represent a significant medical problem and require a high level of therapy to reduce the risk of infection and other long-ter...
This study aimed to provide a transparent protocol and prove the effectiveness of an...
Thirteen female Goettingen minipigs were kept in species-appropriate housing and were treated according to the German law for the protection of animals. The study was performed with permission from th...
The Goettingen minipig model proved to be suitable in wound-healing studies. The dermal regeneration was evident and viewable without wound contamination or any rejection reaction. The histological ev...
Given the great clinical need for alternative or complementary therapies, we considered the Goettingen minipig trial a reliable, ethically justifiable, effective, and reproducible in vivo model for wo...
Evaluate and compare the ability of large language models (LLMs) to diagnose various ailments in otolaryngology....
We collected all 100 clinical vignettes from the second edition of Otolaryngology Cases-The University of Cincinnati Clinical Portfolio by Pensak et al. With the addition of the prompt "Provide a diag...
ChatGPT-3.5 was the most accurate model (89% success rate), followed by Google Bard (82%) and Bing GPT (74%). A chi-squared test revealed a significant difference between the three LLMs in providing c...
ChatGPT-3.5 offers the most accurate diagnoses when given established clinical vignettes as compared to Google Bard and Bing-GPT4. LLMs may accurately offer assessments for common otolaryngology condi...
3 Laryngoscope, 2024....